CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) posted its earnings results on Monday. The company reported ($0.98) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.13) by $1.15, Briefing.com reports. The business had revenue of $70.00 million for the quarter, compared to analysts’ expectations of $1.80 million. CRISPR Therapeutics had a […]
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) issued its earnings results on Monday. The company reported ($0.98) earnings per share for the quarter, beating the consensus estimate of ($2.13) by $1.15, Briefing.com reports. The firm had revenue of $70.00 million for the quarter, compared to analysts’ expectations of $1.80 million. CRISPR Therapeutics had a negative […]
Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.6% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 171,167 shares of the company’s stock after buying an additional 7,565 shares during the period. Mirae […]
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) released its earnings results on Monday. The company reported ($0.98) earnings per share for the quarter, beating the consensus estimate of ($2.13) by $1.15, Briefing.com reports. The firm had revenue of $70.00 million for the quarter, compared to the consensus estimate of $1.80 million. CRISPR Therapeutics had a […]
WealthPlan Investment Management LLC lifted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 17.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,850 shares of the company’s stock after buying an additional 1,301 shares during […]